State Ledger
Company profile

Aptevo Therapeutics Inc. CIK 1671584

Ticker
APVO (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Seattle, WA 98121
Fiscal year end
2025 (FY)
Market Data
Close
$1.84
Change
+$0.04
Change %
2.22%
Volume
5,850

APVO · trading date Oct 12, 2026 · previous close $1.80 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$25.97M
Total assets
$27.19M
Total liabilities
$9.81M
Stockholders' equity
$17.38M
Cash & equivalents
$21.62M
Operating income
-$26.31M
Operating cash flow
-$25.59M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
36.1%
Equity / assets
63.9%
CapEx / revenue
—
Operating cash flow / net income
0.99×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$25.97M $27.19M $9.81M $17.38M
2024 — -$24.13M $15.59M $10.84M $4.76M
2023 — -$17.41M $24.84M $12.62M $12.22M
2022 $3.11M $8.03M $34.22M $16.24M $17.97M
2021 $12.29M -$28.46M $56.60M $55.39M $1.22M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 424B4
2026-09-03
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Seattle, WA 98121
2401 4TH AVE.
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:01 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Washington — Public Companies